Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,406.20
3.10 (0.22%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹425 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
23.8
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,067+31.8%
52W High₹1,774-20.7%
Current Price
₹1,406.20
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,124.96
Upper Circuit₹1,687.44
Reference Price
₹1,406.20
Investment Checklist
Inverse Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹1580.9
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1678.2
Volume divergence: Bullish (price down, volume up)
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price below SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
78%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
EMA20
1466.57
EMA50
1447.84
EMA200
1319.04
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows5
Lower Highs6
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹1420.00
₹1440.50
₹1507.20
₹1539.00
₹1766.95
Support (Below)
₹1380.30
₹1335.00
₹1301.44
₹1241.56
₹1204.37
Volume Analysis
TrendINCREASING
Change+138.00%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹1392.14
3% Risk₹1364.01
5% Risk₹1335.89
7% Risk (Custom)
₹1307.77Technical Levels
1x ATR (Volatility)₹1320.56
2x ATR (Swing)₹1234.92
3x ATR (Trend)₹1149.28
Immediate Support₹1380.30
Moving Averages
EMA 200 (Long-term)₹1319.04
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹84.6 Cr | ₹81.2 Cr | ₹82.5 Cr | ₹81.4 Cr |
| Net Profit | ₹5.5 Cr | ₹3 Cr | ₹4.2 Cr | ₹6.1 Cr |
| EPS | ₹18.08 | — | ₹13.75 | ₹20.19 |
| Operating Profit | ₹12.8 Cr | ₹9.5 Cr | ₹12.7 Cr | ₹14 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 24 Sept 2025 | Dividend - Rs 1.50 Per Share | DIVIDEND |
| 23 Sept 2024 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 22 Sept 2023 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 22 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 20 Sept 2021 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for HALEOSLABS
View AllNEWS
negative
Business Standard - Markets 9d ago
Thacker & Company Ltd leads losers in 'B' group
Mahalaxmi Rubtech Ltd, Haleos Labs Limited, Shah Metacorp Ltd and Umiya Buildcon Ltd are among the other losers in the BSE's 'B' group today, 04 June 2026.
BSEHALEOSLABSMHLXMIRUSHAHTHACKERUMIYA-MROCapital GoodsFinancial Services
NEWS
negative
Business Standard - Markets 11d ago
Worth Peripherals Ltd leads losers in 'B' group
Mahalaxmi Fabric Mills Ltd, Rajdarshan Industries Ltd, Archidply Decor Ltd and Haleos Labs Limited are among the other losers in the BSE's 'B' group today, 02 June 2026.
ADLARCHIDPLYARENTERPBSEHALEOSLABSMFMLWORTHPERICapital GoodsConsumer Durables
NEWS
neutral
Business Standard - Markets 14d ago
Haleos Labs consolidated net profit declines 85.19% in the March 2026 quarter
Sales decline 15.68% to Rs 75.14 crore
HALEOSLABSHealthcare